Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the effects of age on the pharmacokinetic (PK) profile of BIA 9-1067 and its metabolites.

Phase 1

Bial - Portela C S.A.

Opicapone